找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Evidence-based Anticancer Materia Medica; William C.S. Cho Book 2011 Springer Science+Business Media B.V. 2011 Anticancer drug.Complementa

[復(fù)制鏈接]
樓主: Monsoon
51#
發(fā)表于 2025-3-30 08:33:05 | 只看該作者
52#
發(fā)表于 2025-3-30 15:51:52 | 只看該作者
53#
發(fā)表于 2025-3-30 20:07:41 | 只看該作者
An Evidence-based Perspective of , (Lucid Ganoderma) for Cancer Patients,anticancer effects of lucid ganoderma in cell and animal models could be the strong references for the clinical trials. The components with anticancer potential in lucid ganoderma include triterpenoids, steroids, polysaccharides, fatty acids, and novel proteins such as LZ-8. On the basis of . and .
54#
發(fā)表于 2025-3-30 21:47:58 | 只看該作者
An Evidence-based Perspective of , (Multicolored Polypore Mushroom) for Cancer Patients, possible applications for supportive cancer care and therapy. Modulation of innate and adaptive immunity, hematopoietic activity, and direct cytotoxic effects are reviewed with detailed analysis of molecular targets and signaling pathways affected by mushroom components and/or secondary metabolites
55#
發(fā)表于 2025-3-31 01:45:50 | 只看該作者
An Evidence-based Perspective of , (Shiitake Mushroom) for Cancer Patients,tive strategy to control and ultimately overcome cancer. Here, we will summarize the antitumor activity and immunomodulating action of biologically active polysaccharides, mostly β-glucans, from shiitake mushroom fruit bodies and/or cultured mycelium based on experimental and clinical findings. The
56#
發(fā)表于 2025-3-31 06:44:19 | 只看該作者
57#
發(fā)表于 2025-3-31 09:32:19 | 只看該作者
58#
發(fā)表于 2025-3-31 16:52:25 | 只看該作者
59#
發(fā)表于 2025-3-31 20:33:34 | 只看該作者
An Evidence-based Perspective of Herbal Remedies for Cancer Patients,efore acceptance of herbal remedies into wide scale clinical use can be achieved, two critical issues need to be addressed; these include a clearer understanding of their precise mechanism of action, along with supporting empirical clinical data on efficacy. In this chapter, firstly, we describe the
60#
發(fā)表于 2025-4-1 01:31:05 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 13:19
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
修武县| 嘉峪关市| 晋城| 方城县| 衡阳市| 高台县| 绥宁县| 鄱阳县| 安岳县| 敖汉旗| 仁化县| 崇义县| 乳山市| 临城县| 蒲江县| 阳江市| 金昌市| 宜宾市| 垦利县| 平泉县| 三亚市| 河津市| 宁陕县| 祁连县| 大连市| 武功县| 通辽市| 常熟市| 日喀则市| 聊城市| 安康市| 星座| 崇仁县| 文化| 齐齐哈尔市| 大英县| 霞浦县| 云龙县| 富阳市| 涪陵区| 永德县|